Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report)’s share price dropped 2% during trading on Friday . The company traded as low as $1.47 and last traded at $1.47. Approximately 1,000 shares were traded during mid-day trading, a decline of 21% from the average daily volume of 1,267 shares. The stock had previously closed at $1.50.
Silence Therapeutics Price Performance
The firm’s 50-day moving average is $1.91 and its 200 day moving average is $4.38.
Silence Therapeutics Company Profile
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
Featured Articles
- Five stocks we like better than Silence Therapeutics
- Canadian Penny Stocks: Can They Make You Rich?
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Best Stocks Under $10.00
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
